WHO ICTRP trial

Evaluation of the effectiveness of low-dose ketamine (Sub dissociative) with…

IRCT20220120053770N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT20220120053770N1
Public title Evaluation of the effectiveness of low-dose ketamine (Sub dissociative) with dexmedetomidine in controlling pain in patients with limb trauma referred to emergency department
Scientific title Evaluation of the efficacy of low-dose (sub dissociative) ketamine with dexmedetomidine, and its comparison with morphine in controlling pain in patients with limb trauma referred to emergency department of Sina hospital
Primary sponsor Tehran University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions Pain management of limb trauma in emergency department. Acute pain due to trauma;G89.11
Interventions Intervention 1: Intervention group: Intravenous ketamine with sub dissociative dose (0.3 mg / kg) with intravenous dexmedetomidine (1 mcg / kg). Intervention 2: Intervention group: Intravenous morphine (0.1 mg / kg).
Registration date Feb 12, 2022
Target size 258
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations